Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012

Publisher: Select Biosciences
Published: January 2012
Pages: 122

Price:

This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) and cancer stem cells (CSCs) fields. In this report, we focus upon the biology of CTCs and CSCs as well as explore the inter-relationship between these cell types based upon molecular events. Also presented are research trends which are for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastatic mechanisms

This report analyzes the CTCs marketplace from a technical as well as market perspective describing the biology of CTCs, methodologies currently in use for the purification and study of CTCs, as well as the market landscape for CTCs.

This report also describes the current state of the CSC marketplace based on data from research, market landscape, and clinical trial angles

This is the first report in its class providing a technical as well as a market analysis of CTCs and CSCs. Data in this report includes a primary market survey performed describing the research trends currently in the CTCs and CSCs spaces including:

Surface markers currently used to study CTCs and CSCs
Intracellular signaling pathways analyzed in CSCs
Quantitative Breakout of Cancer Classes where CTCs are being studied
Market Shares of Vendors Offering Products into the CTC and CSC Spaces
Breakout of the Marketplace vis-à-vis Technologies/Approaches for Study of CTCs
Quantitative Market Metrics for CTCs Space: Quantitative Market Forecast, Growth Rate

This data-driven characterization of the CTCs and CSCs landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans

Extensive Technical and Market Analyses Presented in this Report

Biology of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)

Characteristics of CTCs and DTCs
EMT Signaling Pathways and Molecular Effectors
Markers for CSCs

Circulating Tumor Cells (CTCs) Research Approaches

Methodologies for Study/Analysis of CTCs
CTC Detection Approaches
New Molecular Targets for CTC Detection Broadening the “CTC Classes” in Various Types of Cancer
Advantages and Disadvantages of Various CTC Analysis Approaches

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Landscape

CTCs and CSCs: Primary Market Research Data, Research Trends
Product Market Shares
Quantitative Market Metrics: Market Sizing, Growth Rate
Clinical Trial Quantitative Metrics and Analysis

Report Table of Contents (TOC) [Click Here to Download PDF File]

For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News

Post Event Lab Tour
On November 14th there will be a post event lab tour, free for Lab-on-a-Chip Asia conference attendees. This will include visits to Singapore Institute of Manufacturing Technology, Nanyang Technological University, and National University of Singapore.

Harnessing the Great Promise of Microfluidics - an interview with Holger Becker
Dr Holger Becker, Chief Scientific Officer of microfluidic ChipShop GmbH, discusses the great potential of microfluidics in our latest blog entry – http://bit.ly/15HpwvN. Dr Becker will also be running a training course on ‘Microfluidics from the Concept to a Product: Technologies, Applications and Commercialisation Strategies’ at ELA on June 5th http://bit.ly/13ovJPE

Trends at the forefront of liquid handling and lab automation
This week we caught up with Joe Liscouski, Executive Director at the Institute for Laboratory Automation (ILA) in MA, USA, to find out more about how the use of liquid handling has evolved over the last decade and to gain some insight into what we can expect next.

5 Reasons Not to Miss ELA 2013
We understand that staying up-to-date on the latest technologies boosting efficiency and effectiveness in the lab can be challenging. That’s exactly why we created ELA. Our latest blog entry - http://bit.ly/15HpwvN - highlights five key reasons not to miss this year’s event, all based on feedback we’ve received from past attendees.

The ethics around biobanking – an interview with Zubin Master
This week’s blog focusses on the ethical issues surrounding biobanking, based on a recent interview we conducted with Zubin Master. Dr Master, Assistant Professor at the Alden March Bioethics Institute of Albany Medical College, will be discussing this topic in detail at ELA 2013 as part of his presentation, “Biobanks: Consent, Consensus & Public Trust.”

New ELA Blog
In the run up to European Lab Automation 2013, we’ll be sharing some interesting news and insights around the event on our new blog - http://tinyurl.com/aafeu9f . We’d be delighted if you’d like to comment on some of our blog posts, adding your own thoughts and generally become a valued part of the conversation!